Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib Plus Simvastatin for COVID-19 Respiratory Failure
NCT04348695Phase 2Completed
- Sponsor
- Fundación de Investigación HM Hospitales
- Start
- Apr 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ruxolitinib, simvastatin in coronavirus disease 2019 (COVID-19), sponsored by Fundación de Investigación HM Hospitales. Started Apr 2020; status: completed.
02
Drugs
ruxolitinibsimvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04348695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04348695.